Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis (2023)
- Authors:
- Silva, Aline Ignacio Silvestre da
- Cipelli, Marcella
- Takiishi, Tatiana
- Aguiar, Cristhiane Favero
- Terra, Fernanda Fernandes
- Nunes, Bruno Ghirotto
- Silva, Eloisa Martins da
- Castoldi, Angela
- Magalhães, Yuli Thamires
- Souza, Tiago Antonio de
- Hiyane, Meire Ioshie
- Oliveira, Vinicius Andrade de
- Forti, Fabio Luis
- Camara, Niels Olsen Saraiva
- USP affiliated authors: HIYANE, MEIRE IOSHIE - ICB ; FORTI, FÁBIO LUÍS - IQ ; CÂMARA, NIELS OLSEN SARAIVA - ICB ; CIPELLI, MARCELLA - ICB ; NUNES, BRUNO GHIROTTO - ICB ; MAGALHÃES, YULI THAMIRES - IQ
- Unidades: ICB; IQ
- DOI: 10.1101/2023.04.26.537895
- Subjects: COLITE; CÉLULAS MIELOIDES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SILVA, Aline Ignacio Silvestre da et al. Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis. bioRxiv, 2023Tradução . . Disponível em: https://doi.org/10.1101/2023.04.26.537895. Acesso em: 13 fev. 2026. -
APA
Silva, A. I. S. da, Cipelli, M., Takiishi, T., Aguiar, C. F., Terra, F. F., Nunes, B. G., et al. (2023). Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis. bioRxiv. doi:10.1101/2023.04.26.537895 -
NLM
Silva AIS da, Cipelli M, Takiishi T, Aguiar CF, Terra FF, Nunes BG, Silva EM da, Castoldi A, Magalhães YT, Souza TA de, Hiyane MI, Oliveira VA de, Forti FL, Camara NOS. Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis [Internet]. bioRxiv. 2023 ;[citado 2026 fev. 13 ] Available from: https://doi.org/10.1101/2023.04.26.537895 -
Vancouver
Silva AIS da, Cipelli M, Takiishi T, Aguiar CF, Terra FF, Nunes BG, Silva EM da, Castoldi A, Magalhães YT, Souza TA de, Hiyane MI, Oliveira VA de, Forti FL, Camara NOS. Lack of mTORC2 signaling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis [Internet]. bioRxiv. 2023 ;[citado 2026 fev. 13 ] Available from: https://doi.org/10.1101/2023.04.26.537895 - Rho pathway: a fragile point in the GBM resistance to radiotherapy
- The Rho GTPase pathway as a potential chemosensitizer of TMZ and cisplatin-resistant GBM through a p53-dependent mechanism
- Glioblastoma: descoberto mecanismo capaz de reverter resistência do tumor cerebral à radioterapia
- ROCK inhibition reduces the sensitivity of mutant p53 glioblastoma to genotoxic stress through a Rac1-driven ROS production
- Gut microbiota resilience mechanisms against pthogen infection and its role in infammatory Bowel Disease
- Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes
- Tear flm immunological profile in patients with ocular graft versus Host Disease
- mTORC1 inhibition in DCs diminishes sepsis symptoms
- Protective role of NKT cells and macrophage M2-drivenphenotype in bleomycin-induced pulmonary fibrosis
- Uric acid signalling via adaptor molecule MYD88 and M1/M2 macrophage balance in the development of renal fibrosis
Informações sobre o DOI: 10.1101/2023.04.26.537895 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
